Journal of Bone and Mineral Research
Author:
- 1 December 1993
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 8 (S2) , S597-S606
Abstract
The bisphosphonates are analogs of naturally occurring pyrophosphate. They appear to block bone resorption much more than mineralization. A series of compounds has been investigated. These have antiresorptive potencies ranging from 1 to 10,000. So far, structure-function relationships have eluded definition. These drugs increase the bone density in women with postmenopausal osteoporosis by about 5%-10% over 1 year. The bone density then appears to plateau, but most studies are of short duration. Improved bone density does not necessarily result in stronger bone, but no studies have had adequate power to assess fracture incidence. Bone formation rates decrease as measured histomorphometrically. This occurs while the bone density is improving, which implies an inhibition of bone resorption that is probably due to direct toxicity to the osteoclasts. Etidronate blocks mineralization as well as resorption and can cause osteomalacia, which is not seen with low-dose cyclical etidronate or with the second-generation compounds. The long-term effects of interfering with the remodeling cycle are still not known. Subtle side effects may be those on the bone itself. These might go undetected, since bone pain or fractures usually are atributable to the underlying disease.Keywords
This publication has 37 references indexed in Scilit:
- BisphosphonatesDrugs, 1991
- Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclastsJournal of Bone and Mineral Research, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Caries-Preventive Effect of Fluoride Dentifrices with and without Anticalculus Agents: A 3-Year Controlled Clinical TrialCaries Research, 1990
- Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)—Osteoporosis study I, HannoverJournal of Molecular Medicine, 1989
- Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateJournal of Bone and Mineral Research, 1989
- Bisphosphonate Effects on Alveolar Bone During Rat Molar DriftingJournal of Dental Research, 1988
- Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1–38)hPTH and diphosphonate EHDPJournal of Molecular Medicine, 1988
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- Diphosphonates: History and mechanisms of actionMetabolic Bone Disease and Related Research, 1981